Interesting facts
Interesting Facts about (2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
The compound known as (2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol showcases fascinating structural and functional features that make it a subject of interest in the field of medicinal chemistry.
- Stereochemistry: This compound is characterized by its specific stereochemistry, denoted by the (2S) configuration. Chirality plays a significant role in influencing the biological activity of molecules, often making one enantiomer more effective than the other.
- Pharmacological Potential: The presence of both the tert-butylamino group and the thiadiazole moiety suggest that this compound could exhibit interesting pharmacological properties, potentially acting as a therapeutic agent in treating various diseases.
- Morpholino Group: The morpholino group incorporated in its structure is known for providing increased lipophilicity and metabolic stability. This feature enhances the compound's absorption and distribution in biological systems.
- Thiadiazole Derivatives: Compounds containing thiadiazole rings, like this one, have been widely studied for their diverse biological activities, which may include antibacterial, antifungal, and anti-inflammatory properties.
- Structure-Activity Relationship: The intricate design of this compound highlights the importance of structure-activity relationships (SAR) in drug design. By modifying different substituents, scientists can explore optimal interactions with biological targets.
As scientists continue to investigate compounds such as (2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol, they pave the way for discovering novel therapeutic agents that could have significant impacts on human health.
Synonyms
timolol
26839-75-8
Betimol
Timololum
Timolol anhydrous
Betim
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
5JKY92S7BR
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
CHEBI:9599
CHEBI:60787
817W3C6175
Timololo
Nyogel
Tiopex
Glau-opt
2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, hemihydrate, (S)-
RefChem:898126
GlyTouCan:G25766AE
C07AA06
S01ED01
1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
MK950
G25766AE
L714,465
L 714,465
248-032-6
CHEBI:39465
(S)-timolol
Timoptic
Blocadren
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
Timololum [INN-Latin]
Timolol (INN)
Betimol (TN)
Timopic
(S)-timolol (anhydrous)
CHEMBL499
DTXSID4023674
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
NCGC00016798-06
Timacar
Timoptol
TIMOLOL [INN]
2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (2S)-
DTXCID203674
(2S)-3-[(tert-butyl)amino]-1-(4-morpholin-4-yl(1,2,5-thiadiazol-3-yl)oxy)propa n-2-ol
2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2S)-
Timolol (TN)
CAS-26839-75-8
HSDB 6533
Timolol [USAN:INN]
EINECS 248-032-6
CAS-26921-17-5
UNII-5JKY92S7BR
(S)-Timolol; Arutimol; L-Timolol
Tocris-0649
TIMOLOL [HSDB]
TIMOLOL [MI]
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Lopac-T-6394
TIMOLOL [WHO-DD]
SCHEMBL4912
Lopac0_001189
Oprea1_640981
BSPBio_000916
GTPL565
BIDD:GT0073
SPBio_003075
BPBio1_001008
HMS2089I11
HMS3259C20
Tox21_110614
BDBM50292219
AKOS015969764
Tox21_110614_1
DB00373
NC00592
NCGC00016038-01
NCGC00016038-02
NCGC00016798-01
NCGC00016798-02
NCGC00016798-03
NCGC00016798-05
NCGC00016798-07
NCGC00016798-08
NCGC00016798-09
NCGC00016798-11
NCGC00016798-20
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-
DA-78480
HY-17494
ST072193
AB00513729
CS-0009238
NS00115928
C07141
D08600
AB00513729-17
839T758
EN300-17982937
Q413994
BRD-K08806317-050-03-6
BRD-K08806317-050-29-1
BRD-K08806317-051-01-8
BRD-K08806317-103-02-5
(2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol
(S)-1-(TERT-BUTYLAMINO)-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol
(S)-Timolol; (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol; 2-Propanol, 1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-, (S)-(-)- (8CI); 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-mor
1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol
Solubility of (2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
The solubility characteristics of (2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol can provide valuable insights into its behavior in various solvents. Understanding solubility is crucial as it influences a compound's bioavailability, reactivity, and potential applications. Here are some key points to consider:
In summary, while solubility data may not be universally available for every specific compound, analyzing the functional groups involved helps to predict solubility trends. It is advisable to conduct empirical solubility tests in both polar and non-polar solvents for a complete understanding. As the saying goes, "Solubility is the key to a compound's true potential."